Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2026

Genmab — Januar 2026

Planlagt Fastgjort Låst Flyttet Genmab
295 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    gentogen
    wrote on sidst redigeret af
    #248

    About EL 10:34. Yes, that may also explain why Genmab split the study, bu t it was quite complex as Roche had severa "Inconsistent results" that did look strange and made it hard to interpret the results. See here for example: https://www.fiercepharma.com/pharma/roches-columvi-expansion-bid-danger-fdas-makary-pazdur-push-changes

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #249

      Sad that Hexabody CD38 did not make it……

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #250

        Just a moment...

        favicon

        (www.fiercebiotech.com)

        1 Reply Last reply
        0
        • Z Offline
          Z Offline
          Zipo
          wrote on sidst redigeret af
          #251

          Er FDA-artiklen en kurs-trigger for Genmab?
          ❌ Kort svar: Nej – ikke i sig selv
          ✅ Længere, præcis vurdering:

          Hvorfor ikke en direkte trigger

          Genmab har ingen egen myelom-studier

          Ingen kommende MRD-readouts

          Ingen regulatoriske events direkte koblet til artiklen

          Hvorfor den alligevel betyder noget

          Forbedrer royalty-option value på BCMA-bispecifics

          Øger strategisk værdi af DuoBody-platformen

          Sænker regulatory risk for myelom-partnerskaber

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #252

            UBS https://x.com/_ShahKruti/status/2014420301191479714

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #253

              RAINFOL-05 (lung) starts recruiting https://clinicaltrials.gov/study/NCT07288177?tab=history&a=2&b=3#version-content-panel

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #254

                New trial sneaking in... : Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT07353957 even started recruiting already...

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #255

                  i wonder if will get to see some early data from the Ph I / II solid tumors trial, on the NSCLC arm, Primary Completion was 2025-11 , but hasn't been updated for a long time https://clinicaltrials.gov/study/NCT03526835

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #256

                    this could put the Acasunlimab decision in a different light (and even GEN1286)

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      peter12
                      wrote on sidst redigeret af
                      #257

                      Spændende artikel om Peto https://www.irbbarcelona.org/en/news/scientific/mcla-158-first-clinical-candidate-screened-organoids-targeting-cancer-stem-cells

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #258

                        small new trial City of Hope - Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/​Refractory Diffuse Large B-Cell Lymphoma
                        https://clinicaltrials.gov/study/NCT07365306

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #259

                          small new trial - Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma https://clinicaltrials.gov/study/NCT07332507

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bb8
                            wrote on sidst redigeret af
                            #260

                            https://endpoints.news/genmab-halts-enrollment-for-cancer-drug-from-profoundbio-buyout/ Genmab halts enrollment for cancer drug from ProfoundBio buyout

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              ProinvestorNEWS
                              wrote on sidst redigeret af
                              #261

                              Go
                              dmorgen 🙂

                              1 Reply Last reply
                              0
                              • B Offline
                                B Offline
                                bibob
                                wrote on sidst redigeret af
                                #262

                                God morgen. 🙂

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  JKY_VH
                                  wrote on sidst redigeret af
                                  #263

                                  Har jeg misset nogle nyheder eller er den bare blevet for billig +1,75% på en studs

                                  1 Reply Last reply
                                  0
                                  • T Offline
                                    T Offline
                                    transalp
                                    wrote on sidst redigeret af
                                    #264

                                    Samme tanke her.. 🙂

                                    1 Reply Last reply
                                    0
                                    • concilladoC Offline
                                      concilladoC Offline
                                      concillado
                                      wrote on sidst redigeret af
                                      #265

                                      Hvornår har aktien ikke været for billig?? 😉

                                      1 Reply Last reply
                                      0
                                      • concilladoC Offline
                                        concilladoC Offline
                                        concillado
                                        wrote on sidst redigeret af
                                        #266

                                        Den ma da gerne falde, når der snart bliver udbetalt udbytte, som skal placeres 😄

                                        1 Reply Last reply
                                        0
                                        • R Offline
                                          R Offline
                                          Raun
                                          wrote on sidst redigeret af
                                          #267

                                          Det ligner en af de dage, hvor US af en eller anden grund handler aktien op

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper